Messages with direct wording and limited data points performed best in a new ZoomRx physician study. (c/o ZoomRx)

On­col­o­gists re­spond best to short, pre­cise and da­ta-rich mar­ket­ing mes­sages, study finds

Look­ing to get an on­col­o­gist’s at­ten­tion with a brand­ed drug mes­sage? Keep it short and sim­ple, but don’t for­get the da­ta. That’s some of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.